A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

P.M. Voorhees, R.F. Manges, P. Sonneveld, S. Jagannath, G. Somlo, A. Krishnan, S. Lentzsch, R.C. Frank, S. Zweegman, P.W. Wijermans, R.Z. Orlowski, B. Kranenburg, B. Hall, T. Casneuf, X. Qin, H. te Velde, H. Xie, S.K. Thomas

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)357-366
JournalBritish Journal of Haematology
Issue number3
Publication statusPublished - 2013

Cite this